Mabgene
Mabgene is a biotechnology company engaged in the development and manufacture of recombinant proteins and monoclonal antibodies by using cell culture techniques on a contract basis. It provides production services using fully documented procedures and state-of-the-art technology by working in close collaboration with its clients for the mutual benefit of both parties. Mabgene is also specialized in the field of expression in different animal cell systems. It has purpose-built positive pressure laboratories specifically for cell growth optimization and the banking of Master and Manufacturers Working Cell Banks. In collaboration with independent testing laboratories, Mabgene is able to offer secure storage facilities, full cell line authentication and microbial QC testing to meet regulatory requirements. The company owns two distinctive production units one which comprises the stages of optimization and the production of biomolecules batches and the other cGMP production unit dedicated to the production of clinical batches. Mabgene is headquartered in Ales Cedex, France.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

